FCG
XBIT icon

Financial Connections Group’s XBiotech XBIT Stock Holding History

Financial Connections Group’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-500
Closed -$1K – 286
2023
Q1 		$1K Hold
500
– – ﹤0.01% 238
2022
Q4 		$1K Hold
500
– – ﹤0.01% 225
2022
Q3 		$1K Hold
500
– – ﹤0.01% 217
2022
Q2 		$2K Hold
500
– – ﹤0.01% 263
2022
Q1 		$4K Hold
500
– – ﹤0.01% 243
2021
Q4 		$5K Buy
+500
New +$6.51K ﹤0.01% 253

Other funds holding XBIT

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Financial Connections Group's XBIT Position: Q2 2023 in Review

Financial Connections Group sold out of XBiotech (XBIT) in Q2 2023, closing a stake of 500 shares — an estimated $1K sold.

Financial Connections Group first reported a position in XBIT in Q4 2021 and held it in 6 quarters. The position peaked at $5K in Q4 2021. 39 funds tracked by Wall St. Rank hold XBIT as of Q2 2023.

  • Financial Connections Group reported no remaining XBiotech position as of Q2 2023 after selling out during the quarter.
  • Financial Connections Group sold 500 XBiotech shares in Q2 2023, an estimated $1K.
  • Financial Connections Group first reported a position in XBiotech in Q4 2021 and held it in 6 quarters.
  • Financial Connections Group's XBiotech position peaked at $5K in Q4 2021.
  • 39 funds tracked by Wall St. Rank held XBiotech as of Q2 2023.

Based on Financial Connections Group's 13F filing for Q2 2023, filed 14 Jul 2023.